Insider filing · VCYT
Marc Stapley
Director
profile →
Veracyte, Inc.
VCYT · Healthcare · 50 filings in 24 months
ticker →
Marc Stapley sold $1.7M of Veracyte (VCYT)
Executed Mar 4 2025, disclosed Mar 6 2025, 2 days later.
Value, as filed
$1.7M
51,603 sh across 2 lots
Executed
Mar 4 2025
the trade date, as filed
Disclosed
Mar 6 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMarc Stapley (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $6.9M of VCYT (138,051 sh × $50.12, as filed), executed Jun 4.
The name
VCYTHealthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Marc Stapley in VCYT
VCYTSALE
Veracyte, Inc.
$6.9M138,051 sh × $50.12
Exec Jun 4
Filed Jun 4 · 5:30 PM ET VCYTSALE Veracyte, Inc. $1.6M
45,523 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET VCYTSALE Veracyte, Inc. $361K
7,668 sh across 2 lots
Exec Dec 4 2025
Filed Dec 4 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $233K
7,667 sh × $30.41
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $225K
5,190 sh × $43.37
Exec Dec 13 2024
Filed Dec 17 2024 · 5:30 PM ET